scholarly journals Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials

2022 ◽  
Author(s):  
Dalton Sholter ◽  
Jianmin Wu ◽  
Bochao Jia ◽  
Hong Zhang ◽  
Kirstin Griffing ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Patient Reported Outcomes ◽  
Active Rheumatoid Arthritis ◽  
Phase 3 ◽  
Two Phase ◽  
Patient Reported ◽  
Post Hoc

scholarly journals Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis

Rheumatology ◽  
2016 ◽  
Vol 55 (6) ◽  
pp. 1031-1041 ◽  
Author(s):  
Vibeke Strand ◽  
Ronald F. van Vollenhoven ◽  
Eun Bong Lee ◽  
Roy Fleischmann ◽  
Samuel H. Zwillich ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Patient Reported Outcomes ◽  
Active Rheumatoid Arthritis ◽  
Placebo Patient ◽  
Phase 3 ◽  
Patient Reported

28194 Patient-reported outcomes of ruxolitinib cream for the treatment of atopic dermatitis: Pooled results from two phase 3 studies

2021 ◽  
Vol 85 (3) ◽  
pp. AB178
Author(s):  
Eric L. Simpson ◽  
Matthias Augustin ◽  
Diamant Thaçi ◽  
Laurent Misery ◽  
Jonathan I. Silverberg ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Patient Reported Outcomes ◽  
Phase 3 ◽  
Two Phase ◽  
Patient Reported
Sign in / Sign up

Export Citation Format

Share Document